{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T16:06:46Z","timestamp":1789229206273,"version":"build-2803163510"},"reference-count":64,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejso.2026.111841","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T23:33:20Z","timestamp":1777073600000},"page":"111841","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Defining disease recurrence after curative treatment of esophageal cancer: a literature review"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6141-9796","authenticated-orcid":false,"given":"T.J.","family":"Huizer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.B.","family":"Schulte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3040-4626","authenticated-orcid":false,"given":"L.V.","family":"Beerepoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4688-2921","authenticated-orcid":false,"given":"N. Haj","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6106-0547","authenticated-orcid":false,"given":"P.M.","family":"Jeene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.A.","family":"Kouwenhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6953-2406","authenticated-orcid":false,"given":"S.L.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.E.","family":"Pouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9678-1611","authenticated-orcid":false,"given":"R.H.A.","family":"Verhoeven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.P.L.","family":"Wijnhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejso.2026.111841_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.ejso.2026.111841_bib2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.14740\/wjon1254","article-title":"Esophageal cancer: an updated surveillance epidemiology and end results database analysis","volume":"11","author":"Then","year":"2020","journal-title":"World J Oncol"},{"issue":"25","key":"10.1016\/j.ejso.2026.111841_bib3","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1200\/JCO.20.03697","article-title":"Randomized study on dose escalation in definitive chemoradiation for patients with locally advanced esophageal cancer (ARTDECO study)","volume":"39","author":"Hulshof","year":"2021","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2026.111841_bib4","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/bjs\/znac290","article-title":"Population-based study of treatment and outcome of recurrent oesophageal or junctional cancer","volume":"109","author":"Pape","year":"2022","journal-title":"Br J Surg"},{"issue":"23","key":"10.1016\/j.ejso.2026.111841_bib5","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMra035010","volume":"349","author":"Enzinger","year":"2003","journal-title":"Esophageal cancer N Engl J Med"},{"issue":"9","key":"10.1016\/j.ejso.2026.111841_bib6","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S1470-2045(15)00040-6","article-title":"Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): Long-Term results of a randomised controlled trial","volume":"16","author":"Shapiro","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2026.111841_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bpg.2018.11.011","article-title":"The role of definitive chemoradiation in patients with non-metastatic oesophageal cancer","volume":"36\u201337","author":"Jeene","year":"2018","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"22","key":"10.1016\/j.ejso.2026.111841_bib8","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"Van Hagen","year":"2012","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.ejso.2026.111841_bib9","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1245\/s10434-013-2936-3","article-title":"Survival after recurrent esophageal carcinoma has not improved over the past 18 years","volume":"20","author":"Blom","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2026.111841_bib10","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/s11605-007-0385-7","article-title":"Surgical outcomes in esophageal cancer patients with tumor recurrence after curative esophagectomy","volume":"12","author":"Kunisaki","year":"2008","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"10.1016\/j.ejso.2026.111841_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"Cunningham","year":"2006","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ejso.2026.111841_bib12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1200\/JCO.2013.51.2186","article-title":"Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials","volume":"32","author":"Oppedijk","year":"2014","journal-title":"J Clin Oncol"},{"issue":"32","key":"10.1016\/j.ejso.2026.111841_bib13","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1200\/JCO-25-00948","article-title":"Recurrence patterns of esophageal adenocarcinoma in the phase III ESOPEC trial comparing perioperative chemotherapy with preoperative chemoradiotherapy","volume":"43","author":"Hoeppner","year":"2025","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2026.111841_bib14","first-page":"1","article-title":"Definitive chemoradiation for locoregional recurrences of esophageal cancer after primary curative treatment","volume":"30","author":"Jeene","year":"2017","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.ejso.2026.111841_bib15","doi-asserted-by":"crossref","first-page":"S1292","DOI":"10.1245\/s10434-015-4840-5","article-title":"Prognosis and treatment after diagnosis of recurrent esophageal carcinoma following esophagectomy with curative intent","volume":"22","author":"Parry","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2026.111841_bib16","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1245\/s10434-010-1024-1","article-title":"7th edition of the AJCC cancer staging manual: esophagus and esophagogastric junction","volume":"17","author":"Rice","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.111841_bib17","first-page":"1","article-title":"Japanese classification of esophageal cancer","volume":"14","year":"2017","journal-title":"11th edition: part I Esophagus"},{"issue":"1","key":"10.1016\/j.ejso.2026.111841_bib18","first-page":"37","article-title":"Japanese classification of esophageal cancer","volume":"14","year":"2017","journal-title":"11th edition: Part II and III Esophagus"},{"issue":"1","key":"10.1016\/j.ejso.2026.111841_bib19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jtho.2016.10.016","article-title":"Cancer of the esophagus and esophagogastric junction: an eighth edition staging primer","volume":"12","author":"Rice","year":"2017","journal-title":"J Thorac Oncol"},{"issue":"Suppl 6","key":"10.1016\/j.ejso.2026.111841_bib20","first-page":"109","article-title":"[japanese classification of esophageal cancer, the 10th edition--pathological part]","volume":"69","author":"Shimoda","year":"2011","journal-title":"Nihon Rinsho"},{"issue":"2","key":"10.1016\/j.ejso.2026.111841_bib21","first-page":"93","article-title":"The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejso.2026.111841_bib22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1471-2407-11-181","article-title":"Chemotherapy followed by surgery versus surgery alone in patients with resectable oesophageal squamous cell carcinoma: long-Term results of a randomized controlled trial","volume":"11","author":"Boonstra","year":"2011","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2026.111841_bib23","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.jtcvs.2022.08.009","article-title":"Prognostic value of recurrence pattern in locally advanced esophageal squamous cell carcinoma: results from the phase III trial NEOCRTEC5010","volume":"165","author":"Chen","year":"2023","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ejso.2026.111841_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/dote\/doaa079","article-title":"Robot-assisted minimally invasive thoracolaparoscopic esophagectomy versus open esophagectomy: Long-term follow-up of a randomized clinical trial","volume":"33","author":"de Groot","year":"2020","journal-title":"Dis Esophagus"},{"issue":"18","key":"10.1016\/j.ejso.2026.111841_bib25","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1200\/JCO.20.03614","article-title":"Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS trial","volume":"39","author":"Eyck","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2026.111841_bib26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejca.2020.08.002","article-title":"Recurrence patterns after neoadjuvant chemoradiotherapy compared with surgery alone in oesophageal squamous cell carcinoma: results from the multicenter phase III trial NEOCRTEC5010","volume":"138","author":"Liu","year":"2020","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.ejso.2026.111841_bib27","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/s41416-022-01726-5","article-title":"Multicenter randomised trial of two versus three courses of preoperative cisplatin and fluorouracil plus docetaxel for locally advanced oesophageal squamous cell carcinoma","volume":"126","author":"Makino","year":"2022","journal-title":"Br J Cancer"},{"issue":"12","key":"10.1016\/j.ejso.2026.111841_bib28","doi-asserted-by":"crossref","first-page":"e2151","DOI":"10.1002\/onco.13914","article-title":"Postoperative adjuvant therapy versus surgery alone for stage iib-III esophageal squamous cell carcinoma: a phase III randomized controlled trial","volume":"26","author":"Ni","year":"2021","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.ejso.2026.111841_bib29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/bjs.9959","article-title":"Patterns of recurrence in early-stage oesophageal cancer after chemoradiotherapy and surgery compared with surgery alone","volume":"103","author":"Robb","year":"2016","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.ejso.2026.111841_bib30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/ags3.12388","article-title":"Long-term results of a randomized controlled trial comparing neoadjuvant adriamycin, cisplatin, and 5-fluorouracil vs docetaxel, cisplatin, and 5-fluorouracil followed by surgery for esophageal cancer (ogsg1003)","volume":"5","author":"Sugimura","year":"2021","journal-title":"Ann Gastroenterol Surg"},{"issue":"7","key":"10.1016\/j.ejso.2026.111841_bib31","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/bjs.10121","article-title":"Multicentre study of neoadjuvant chemotherapy for stage i and II oesophageal cancer","volume":"103","author":"Bekkar","year":"2016","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2026.111841_bib32","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/1749-8090-8-215","article-title":"Recurrence risk after ivor lewis oesophagectomy for cancer","volume":"8","author":"du Rieu","year":"2013","journal-title":"J Cardiothorac Surg"},{"issue":"1","key":"10.1016\/j.ejso.2026.111841_bib33","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/bjs.10334","article-title":"Patterns of recurrence after oesophagectomy and postoperative chemoradiotherapy versus surgery alone for oesophageal squamous cell carcinoma","volume":"104","author":"Hsu","year":"2017","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.ejso.2026.111841_bib34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13019-019-0883-1","article-title":"Pattern of recurrence and prognostic factors in patients with pt1-3 n0 esophageal squamous cell carcinoma after surgery: analysis of a single center experience","volume":"14","author":"Lin","year":"2019","journal-title":"J Cardiothorac Surg"},{"issue":"10","key":"10.1016\/j.ejso.2026.111841_bib35","doi-asserted-by":"crossref","first-page":"7698","DOI":"10.1007\/s00464-023-10334-0","article-title":"Impact of minimally invasive total mesoesophageal excision and minimally invasive esophagectomy on failure patterns of locally advanced esophageal squamous cell carcinoma: a matched cohort study with long-term follow-up","volume":"37","author":"Lin","year":"2023","journal-title":"Surg Endosc"},{"issue":"12","key":"10.1016\/j.ejso.2026.111841_bib36","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1245\/s10434-013-3102-7","article-title":"Different recurrence pattern after neoadjuvant chemoradiotherapy compared to surgery alone in esophageal cancer patients","volume":"20","author":"Smit","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2026.111841_bib37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00000658-200208000-00005","article-title":"Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus","volume":"236","author":"Altorki","year":"2002","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.ejso.2026.111841_bib38","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jtcvs.2018.09.136","article-title":"Patterns and risk of recurrence in patients with esophageal cancer with a pathologic complete response after chemoradiotherapy followed by surgery","volume":"157","author":"Barbetta","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"10.1016\/j.ejso.2026.111841_bib39","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/jso.24808","article-title":"Recurrence patterns and associated factors of locoregional failure following neoadjuvant chemoradiation and surgery for esophageal cancer","volume":"117","author":"Blackham","year":"2018","journal-title":"J Surg Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2026.111841_bib40","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/ijc.34417","article-title":"Incidence and management of esophageal cancer recurrence to regional lymph nodes after curative esophagectomy","volume":"152","author":"Boerner","year":"2023","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.ejso.2026.111841_bib41","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.athoracsur.2021.07.101","article-title":"Treatment of anastomotic recurrence after esophagectomy","volume":"114","author":"Carr","year":"2022","journal-title":"Ann Thorac Surg"},{"issue":"14","key":"10.1016\/j.ejso.2026.111841_bib42","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/cncr.28703","article-title":"Patterns of recurrence after trimodality therapy for esophageal cancer","volume":"120","author":"Dorth","year":"2014","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ejso.2026.111841_bib43","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/bjs5.30","article-title":"Patterns of recurrence in oesophageal cancer following oesophagectomy in the era of neoadjuvant chemotherapy","volume":"1","author":"Knight","year":"2017","journal-title":"BJS Open"},{"issue":"12","key":"10.1016\/j.ejso.2026.111841_bib44","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1097\/01.JTO.0000437420.38972.fb","article-title":"Esophageal cancer recurrence patterns and implications for surveillance","volume":"8","author":"Lou","year":"2013","journal-title":"J Thorac Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2026.111841_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2023.05.022","article-title":"Patterns of recurrent disease after neoadjuvant chemoradiotherapy and esophageal cancer surgery with curative intent in a tertiary referral center","volume":"49","author":"Schuring","year":"2023","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2026.111841_bib46","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1053\/j.semtcvs.2022.04.008","article-title":"Patterns of recurrence after robot-assisted minimally invasive esophagectomy in esophageal squamous cell carcinoma","volume":"35","author":"Yang","year":"2023","journal-title":"Semin Thorac Cardiovasc Surg"},{"issue":"9","key":"10.1016\/j.ejso.2026.111841_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/dote\/dox082","article-title":"Treatment strategies in recurrent esophageal or junctional cancer","volume":"30","author":"Butter","year":"2017","journal-title":"Dis Esophagus"},{"issue":"1","key":"10.1016\/j.ejso.2026.111841_bib48","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.radonc.2010.04.029","article-title":"Pattern of relapse in surgical treated patients with thoracic esophageal squamous cell carcinoma and its possible impact on target delineation for postoperative radiotherapy","volume":"96","author":"Cai","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejso.2026.111841_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.652365","article-title":"Pattern of recurrence in 428 patients with thoracic esophageal squamous cell carcinoma after radical surgery and its implication in postoperative radiotherapeutic clinical target volume","volume":"11","author":"Cui","year":"2021","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2026.111841_bib50","doi-asserted-by":"crossref","first-page":"403","DOI":"10.5090\/jcs.23.050","article-title":"The prognostic value of oligo-recurrence following esophagectomy for esophageal cancer","volume":"56","author":"Kang","year":"2023","journal-title":"J Chest Surg"},{"issue":"1","key":"10.1016\/j.ejso.2026.111841_bib51","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3892\/ol.2012.946","article-title":"Characteristics of recurrence after radical esophagectomy with two-field lymph node dissection for thoracic esophageal cancer","volume":"5","author":"Li","year":"2013","journal-title":"Oncol Lett"},{"issue":"1","key":"10.1016\/j.ejso.2026.111841_bib52","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1186\/s12885-023-11568-w","article-title":"Survival outcomes of esophageal cancer patients with recurrence after curative treatments","volume":"23","author":"Sugawara","year":"2023","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2026.111841_bib53","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.canrad.2022.09.001","article-title":"Pattern of relapse following three-field lymphadenectomy of esophageal carcinoma and related factors predictive of recurrence","volume":"27","author":"Xu","year":"2023","journal-title":"Cancer Radiother"},{"issue":"8","key":"10.1016\/j.ejso.2026.111841_bib54","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.ejso.2021.02.001","article-title":"Patterns of recurrence following definitive chemoradiation for patients with proximal esophageal cancer","volume":"47","author":"de Vos-Geelen","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2026.111841_bib55","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1245\/s10434-012-2824-2","article-title":"Survival after definitive (chemo)radiotherapy in esophageal cancer patients: a population-based study in the north-east Netherlands","volume":"20","author":"Smit","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.111841_bib56","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000480515","article-title":"Patterns of relapse after definitive chemoradiotherapy in stage II\/III (non-T4) esophageal squamous cell carcinoma","volume":"94","author":"Sudo","year":"2018","journal-title":"Oncology"},{"issue":"5","key":"10.1016\/j.ejso.2026.111841_bib57","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/dote.12215","article-title":"Definitive chemoradiation for patients with inoperable and\/or unresectable esophageal cancer: locoregional recurrence pattern","volume":"28","author":"Versteijne","year":"2015","journal-title":"Dis Esophagus"},{"issue":"10","key":"10.1016\/j.ejso.2026.111841_bib58","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1002\/cncr.26586","article-title":"Failure patterns in patients with esophageal cancer treated with definitive chemoradiation","volume":"118","author":"Welsh","year":"2012","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.ejso.2026.111841_bib59","doi-asserted-by":"crossref","first-page":"6976","DOI":"10.21037\/jtd-23-1789","article-title":"Long-term clinical outcomes and prognosis after definitive radiotherapy for patients with cervical esophageal squamous cell carcinoma: a single-institution retrospective study","volume":"15","author":"Zhang","year":"2023","journal-title":"J Thorac Dis"},{"issue":"2","key":"10.1016\/j.ejso.2026.111841_bib60","first-page":"106","article-title":"Minimally invasive versus open esophagectomy for resectable thoracic esophageal cancer (nst 1502): a multicenter prospective cohort study","volume":"3","author":"Mao","year":"2023","journal-title":"J Natl Cancer Cent"},{"issue":"28","key":"10.1016\/j.ejso.2026.111841_bib61","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.1200\/JCO.23.00139","article-title":"Pathologic lymph node regression after neoadjuvant chemotherapy predicts recurrence and survival in esophageal adenocarcinoma: a multicenter study in the United Kingdom","volume":"41","author":"Moore","year":"2023","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2026.111841_bib62","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1159\/000527196","article-title":"Recurrence pattern comparing preoperative chemoradiotherapy and preoperative chemotherapy with docetaxel plus 5-fluorouracil and cisplatin for advanced esophageal cancer","volume":"100","author":"Sugase","year":"2022","journal-title":"Oncology"},{"issue":"1","key":"10.1016\/j.ejso.2026.111841_bib63","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1186\/s12885-019-5761-7","article-title":"Distribution of lymph node metastases in esophageal carcinoma [TIGER study]: study protocol of a multinational observational study","volume":"19","author":"Hagens","year":"2019","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.ejso.2026.111841_bib64","doi-asserted-by":"crossref","DOI":"10.1093\/dote\/doad065","article-title":"History and evidence for state of the art of lymphadenectomy in esophageal cancer surgery","volume":"37","author":"Schuring","year":"2024","journal-title":"Dis Esophagus"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326004609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326004609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:47:05Z","timestamp":1781333225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326004609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":64,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0748798326004609"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111841","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defining disease recurrence after curative treatment of esophageal cancer: a literature review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111841","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"111841"}}